CD63 and lung carcinoma: Kristine et al. [57] developed an EV Array that coupled 37 antibodies targeting lung cancer-associated proteins and a panel of CD9, CD63, and CD81 antibodies to explore circulating exosomes from healthy subjects and lung cancer patients.